Genentech, breast cancer
Genentech Itovebi Gets FDA Approval for Treating Breast Cancer
Roche Group unit Genentech said that the Food and Drug Administration approved Itovebi for treating certain breast cancer. The approval is for Itovebi in combination with palbociclib and fulvestrant and for treating adults a certain locally advanced or metastatic breast cancer,
As an FDA-mandated rule goes into effect requiring healthcare providers to notify women of their breast density, the American ...
This first successful treatment of tumors with radioactive ion beams could one day lead to treating human patients’ tumors with millimeter precision.
Northwestern Medicine investigators have discovered that a novel combination therapy promotes cancer cell death and tumor ...
The study focused on urothelial carcinoma, the most common form of bladder cancer, and used advanced whole-genome sequencing ...
The 75-year-old monarch’s diagnosis was shared in a February statement stating that he would “undertake State business and ...
"The Office" actress Jenna Fischer on Tuesday revealed that she was diagnosed with breast cancer last year but is now ...
Swiss Alpine skier Niels Hintermann was diagnosed with lymph node cancer and will miss the upcoming season to undergo ...
It can be difficult to know where to start when you're facing challenging health news — but this list will prepare you for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback